Blood biomarkers of mild traumatic brain injury: State of art
- 19 January 2021
- journal article
- review article
- Published by Elsevier BV in Neurochirurgie
- Vol. 67 (3), 249-254
- https://doi.org/10.1016/j.neuchi.2021.01.001
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based updateBMC Medicine, 2013
- S100B protein in tissue development, repair and regenerationWorld Journal of Biological Chemistry, 2013
- Clinical validation of S100B use in management of mild head injuryBMC Emergency Medicine, 2012
- Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort studyThe Lancet, 2012
- Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and αII-Spectrin Breakdown Product 145 kDa Correlate with Outcome after Pediatric TBIJournal of Neurotrauma, 2012
- Extracranial Sources of S100B Do Not Affect Serum LevelsPLOS ONE, 2010
- Can Low Serum Levels of S100B Predict Normal CT Findings After Minor Head Injury in Adults?Journal of Head Trauma Rehabilitation, 2010
- Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort studyThe Lancet, 2009
- Biochemical, Structural, and Biomarker Evidence for Calpain-Mediated Cytoskeletal Change After Diffuse Brain Injury Uncomplicated by ContusionJournal of Neuropathology and Experimental Neurology, 2009
- Immediate computed tomography or admission for observation after mild head injury: cost comparison in randomised controlled trialBMJ, 2006